Jacob Bitran is an Oncology physician affiliated with Advocate Lutheran General Hospital. OpenAlex indexes 200 publications with 4,536 citations (h-index 38); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1700 Luther Ln
Park Ridge, IL 600681270
Telephone
847-268-8200Provider last certified this registry record 15 Dec 2021.
Clinical trials
- Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis
Sponsor: Wake Forest University Health Sciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Johnson & Johnson Health Care Systems Inc.Program year20251 payment
- Incyte CorporationProgram year20241 payment
- Pharmacyclics LLC, An AbbVie CompanyProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 1987–1988 per NIH RePORTER. The latest:
- PATIENT W/REFRACTORY LYMPHOMA &DISSEMINATED CARCINOMA: CHEMOTHERAPY/BONE MARROW
Illinois Cancer Center
FY1988S07RR005893 - PHASE 1 II BIALKYLATOR BONE MARROW REFUSION IN LYMPHOMA &DISSEMINATED CANCER
Illinois Cancer Center
FY1987S07RR005893
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study
Leukemia & lymphoma/Leukemia and lymphoma
2022 - A Comparison of HLA-Identical Sibling Allogeneic versus Autologous Transplantation for Diffuse Large B Cell Lymphoma: A Report from the CIBMTR
Biology of Blood and Marrow Transplantation
2009
Similar KOLs
Other experts from the same institution or the same specialty.
Lewis Schwartz, MD
Advocate Lutheran General Hospital
Faisal Fecto, MD, PhD
Advocate Lutheran General Hospital
Harrah Chiang, DO
Advocate Lutheran General Hospital
Sydney Brandwein, MD
Advocate Lutheran General Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”